Interleukin-10 gene polymorphism in bone marrow transplant recipients

Experimental and Clinical Transplantation

Volumn 6, Issue 1, 2008, Pages 74-79

  Azarpira, Negar ^a   Ramzi, Mani ^a   Aghdaie, Mahdokht Hossein ^a   Darai, Masumeh ^a   Geramizadeh, Bita ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Donor; Hematopoietic cell; IL 10; PCR; Recipient

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOSINE; GUANINE; HLA ANTIGEN; INTERLEUKIN 10; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DNA POLYMORPHISM; DRUG BLOOD LEVEL; GENE AMPLIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GRAFT RECIPIENT; HAPLOTYPE; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IRAN; LIVING DONOR; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL MOBILIZATION; ACUTE DISEASE; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; GENETICS; GRAFT VERSUS HOST REACTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-10; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSPLANTATION, HOMOLOGOUS;

EID: 46049097022     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bertinetto FE, Dall'Omo AM, Mazzola GA, et al. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int J Immunogenet. 2006;33(5):375-384.
2. Kim DH, Lee NY, Sohn SK, et al. IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation. Transplantation. 2005;79(11):1615-1622.
3. Lin MT, Storer B, Martin PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003;349(23):2201-2210.
4. Hutchinson IV, Turner DM, Sankaran D, Awad MR, Sinnott PJ. Influence of cytokine genotypes on allograft rejection. Transplant Proc. 1998;30(3):862-863.
5. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209-1220.
6. Rennick DM, Fort MM, Davidson NJ. Studies with IL-10-/- mice: an overview. J Leukoc Biol. 1997;61(4):389-396.
7. Cooke KR, Ferrara JL. A protective gene for graft-versus-host disease. N Engl J Med. 2003;349(23):2183-2184.
8. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol. 1992;148(11):3618-3623.
9. Turner D, Grant SC, Yonan N, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation. 1997;64(5):776-779.
10. Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int. 1999;56(1):281-288.
11. Asderakis A, Sankaran D, Dyer P, et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation. 2001;71(5):674-677.
12. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4):295-304.
13. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol. 1999;7(2):127-128.
14. Azarpira N, Aghdaie MH, Geramizadeh B, et al. Cytokine gene polymorphisms in renal transplant recipients. Exp Clin Transplant. 2006;4(2):528-531.
15. Kim DH, Lee NY, Sohn SK, et al. IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation. Transplantation. 2005;79(11):1615-1622.
16. Miura Y, Thoburn CJ, Bright EC, Chen W, Nakao S, Hess AD. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. Blood. 2002;100(7):2650-3658.
17. Mullighan C, Heatley S, Doherty K, et al. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation. 2004;77(4):587-596.
18. Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E; Eurobank members. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol. 2004;127(5):479-490.
19. Holler E, Kolb HJ, Möller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood. 1990;75(4):1011-1016.
20. Middleton PG, Taylor PR, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood. 1998;92(10):3943-3948.
21. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999;94(11):3941-3946.
22. Lin MT, Gooley T, Hansen JA, et al. Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood. 2001;98(10):3172-3173.
23. Socié G, Loiseau P, Tamouza R, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001;72(4):699-706.